Creso Pharma Limited COPHF
Day range unavailable
52-week range unavailable
P/E 0.0×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA -0.4×
EV/Sales 0.5×
FCF Yield 0.0%
Gross Margin 12.3%
Operating Margin -88.2%
Net Margin -277.2%
ROE 1292.4%
ROIC -298.5%
ROA -275.4%
Revenue 117.8%
Operating Income 14.8%
EPS (diluted) 100.0%
Free Cash Flow 72.9%
Current Ratio 0.2×
Quick Ratio 0.2×
Debt / Equity -2.4×
Net Debt / EBITDA -0.4×
Interest Coverage -1.7×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31